Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study-Reference-Cited by-同舟云学术

Feasibility of methotrexate discontinuation following tocilizumab and methotrexate combination therapy in patients with long-standing and advanced rheumatoid arthritis: a 3-year observational cohort study

Published:2023 Issue:1 Volume:69 Page:11-20
ISSN:0016-2590
Container-title:FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
language:en
Short-container-title:FJMS

Author:

Miyata Masayuki¹,Hirabayashi Yasuhiko²,Munakata Yasuhiko³,Urata Yukitomo⁴,Saito Koichi⁵,Okuno Hiroshi⁶,Yoshida Masaaki⁷,Kodera Takao⁸,Watanabe Ryu⁹,Miyamoto Seiya¹⁰,Ishii Tomonori¹¹,Nakazawa Shigeshi¹²,Takemori Hiromitsu¹³,Ando Takanobu¹⁴,Kanno Takashi¹⁵,Komagamine Masataka¹⁶,Kato Ichiro⁶,Takahashi Yuichi¹⁷,Komatsuda Atsushi¹⁸,Endo Kojiro¹⁹,Murai Chihiro²⁰,Takakubo Yuya²¹,Miura Takao²²,Sato Yukio²³,Ichikawa Kazunobu²⁴,Konta Tsuneo²⁵,Chiba Noriyuki²⁶,Muryoi Tai²⁷,Kobayashi Hiroko²⁸,Fujii Hiroshi¹¹,Sekiguchi Yukio²⁹,Hatakeyama Akira⁶,Ogura Ken³⁰,Sakuraba Hirotake³¹,Asano Tomoyuki³²,Kanazawa Hiroshi¹³,Suzuki Eiji¹⁵,Takasaki Satoshi³³,Asakura Kenichi³⁴,Suzuki Yoko³⁵,Takagi Michiaki²¹,Nakayama Takahiro³⁶,Watanabe Hiroshi³²,Miura Keiki³⁷,Mori Yu³⁸,

Affiliation:

1. Department of Internal Medicine, Fukushima Red Cross Hospital

2. Department of Rheumatology, Hikarigaoka Spellman Hospital

3. Munakata Yasuhiko Clinic

4. Department of Rheumatology, Tsugaru General Hospital

5. Suminoya Rheumatism & Orthopedics Clinic

6. Department Orthopedic Surgery, Tohoku Rosai Hospital

7. Yoshida Orthopedic Surgery and Rheumatology Clinic

8. Center for Arthritis and Rheumatic Diseases, Tohoku Pharmaceutical University Hospital

9. Department of Advanced Medicine for Rheumatic Diseases, Graduate School of Medicine, Kyoto University

10. Department of Orthopedic Surgery, Tohoku Orthopedic Clinic

11. Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine

12. Nakazawa Sports Clinic

13. Department of Rheumatology, Aomori Prefectural Central Hospital

14. Department of Orthopedics, General Hanamaki Hospital

15. Department of Rheumatology, Ohta Nishinouchi Hospital

16. Komagamine Orthopedic and Rheumatology Clinic

17. Yu Family Clinic

18. Department of Internal Medicine, Ogachi Central Hospital

19. Department of Rheumatology and Department of Orthopedic Surgery, Hoshi General Hospital

20. Murai Clinic

21. Department of Orthopedic Surgery, Yamagata University Faculty of Medicine

22. Department of Orthopedic Surgery, Hirosaki Memorial Hospital

23. Department of Rheumatology, Kaiyama Central Hospital

24. Department of Cardiology, Pulmonology, and Nephrology, Yamagata University Faculty of Medicine

25. Department of Public Health and Hygiene/Nephrology and Collagen Disease

26. Department of Internal Medicine, Morioka National Hospital

27. Muryoi Clinic

28. Minami-Fukushima Clinic

29. NTT East Tohoku Hospital

30. Ogura Orthopedic Surgery Clinic

31. Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine

32. Department of Rheumatology and Collagen Disease, Fukushima Medical University Hospital

33. Department of Internal Medicine, Saiseikai Yamagata Hospital

34. Department of Internal Medicine, Yuri Kumiai General Hospital

35. Izumi Himawari Clinic

36. Department of Internal Medicine, Nihonkai General Hospital

37. Department of Orthopedic Surgery, Wakuya-Town National Health Insurance Hospital

38. Department of Orthopedic Surgery, Tohoku University Graduate School of Medicine

Publisher

The Fukushima Society of Medical Science

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/fms/69/1/69_2022-06/_pdf

Reference20 articles.

1. 1. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs:2019 update. Ann Rheum Dis, 79:685-699, 2020. https://doi.org/10.1136/annrheumdis-2019-216655.

2. 2. Kerschbaumer A, Sepriano A, Smolen JS, et al. Efficacy of pharmacological treatment in rheumatoid arthritis:A systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis, 79:744-759, 2020. https://doi.org/10.1136/annrheumdis-2019-216656.

3. 3. Nam JL, Winthrop KL, van Vollenhoven RF, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs:a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis, 69:976-986, 2010. https://doi.org/10.1136/ard.2009.126573.

4. 4. Silvagni E, Bortoluzzi A, Carrara G, Zanetti A, Govoni M, Scirè CA. Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis:a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative database. BMJ Open. 2018;8:e021447. http://dx.doi.org/10.1136/bmjopen-2017-021447.

5. 5. Finzel S, Kraus S, Figueiredo CP, et al. Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis. Ann Rheum Dis, 78:1186-1191, 2019. https://doi.org/10.1136/annrheumdis-2018-214894.